<DOC>
	<DOCNO>NCT00830401</DOCNO>
	<brief_summary>This comparative , control trial evaluate impact treat undetected , asymptomatic , predefined minor uterine cavity abnormality success IVF treatment .</brief_summary>
	<brief_title>The Impact Treating Minor Uterine Cavity Abnormalities Diagnosed Office Hysteroscopy Unselected In Vitro Fertilization ( IVF ) Cases</brief_title>
	<detailed_description>Introduction- Implantation failure IVF may due endometrial function , embryo quality combination . The prevalence minor intracavitary pathology case apparent normal transvaginal sonography ( TVS ) observe hysteroscopy record 25-40 % . Treatment pathology prior initiate IVF/ICSI advocate without high-quality evidence . Objective- To evaluate impact treat undetected , asymptomatic , predefined minor uterine cavity abnormality success IVF treatment . Material &amp; methods- Patients , indicate first IVF/ICSI treatment cycle UMC Utrecht AZ-VUB Brussels , initially underwent TVS . In case normal TVS patient schedule hysteroscopy early-mid follicular phase cycle , one three month start IVF/ICSI treatment . Vaginoscopic hysteroscopy perform ambulatory office setting . During hysteroscopy biopsy take , diagnose chronic endometrial inflammation . In case finding predefined intra uterine abnormality ( polyp , myoma , adhesion , septum , endometrial inflammation ) randomisation take place prior hysteroscopy inform consent obtain endoscopy treatment versus treatment . Shortly hysteroscopy , IVF/ICSI treatment initiate outcome one year treatment period record .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Urogenital Abnormalities</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Normal Transvaginal Ultrasound No prior hysteroscopy Regular menstrual cycle Single embryo transfer BMI 18 29 Presence ovary Primary secondary infertility Women indicate first IVF/ICSI cycle Recurrent miscarriage Prior hysteroscopic treatment Endometriosis &gt; AFS Stage II Menometrorrhagia ( define intermenstrual loss blood ) Submucosal/Intracavitary Fibroids take 50 % cavity Hydrosalpinx FSH/LH &gt; 12IU/L day 3 Polyps take 50 % cavity Severe adhesion &gt; grade II</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>intra-uterine abnormality</keyword>
	<keyword>intracavitary pathology</keyword>
	<keyword>hysteroscopy</keyword>
	<keyword>IVF</keyword>
	<keyword>ICSI</keyword>
	<keyword>polyp</keyword>
	<keyword>myoma</keyword>
	<keyword>adhesion</keyword>
	<keyword>septum</keyword>
	<keyword>endometritis</keyword>
</DOC>